← FDA Drug Approvals (Drugs@FDA)
ENZALUTAMIDE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: HAIMEN PHARMA INC · Approved 2025-06-24
Drug application
- FDA Application #
ANDA219675- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- ENZALUTAMIDE
- Generic name
- Enzalutamide
- Active ingredients
- ENZALUTAMIDE
- Dosage form
- TABLET
- Route
- —
- Marketing status
- None (Tentative Approval)
- Sponsor
- HAIMEN PHARMA INC
- First approval
- 2025-06-24
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown